U.K. Surgical Pledgets Market

U.K. Surgical Pledgets Market Outlook

• The industry was valued at US$ 15.3 Mn in 2023
• It is projected to grow at a CAGR of 5.5% from 2024 to 2034 and reach more than US$ 27.5 Mn by the end of 2034

Analyst Viewpoint

Increase in prevalence of cardiovascular disorders, rise in geriatric population, growth in investments in healthcare infrastructure, and advancements in surgical technologies are primarily boosting the U.K. surgical pledgets market size.

Surgical pledgets function as buttresses or pads between the suture area and the tissue surface in order to increase the area of load bearing and secure support for fragile tissues. Constant innovation in product features to improve safety and effectiveness of surgical pledgets is also fostering market progress.

Companies operating in the U.K. surgical pledgets market are developing innovative medical devices that are safe, effective, and accessible.

In line with the recent U.K. surgical pledgets industry trends, several players are collaborating and partnering with leading healthcare entities and research institutions to improve features of surgical pledgets and mitigate associated risk factors.

U.K. Surgical Pledgets Market Overview

Surgical pledgets or surgical suture accessories are mesh-like structures that are intended to enhance surgical suturing process during procedures such as valvular suturing, septal repair, myocardial closure, and hepatic repair.

U.K. surgical pledgets market ensure space between tissues and sutures, thereby lowering the chances of sutures tearing through delicate tissues. Numerous surgical pledgets of various shapes and sizes are commercially available in the market.

The cushioning offered by pledgets also mitigates the risk of tissue rupture or friction. These surgical accessories are used in several surgical applications, which is fueling the surgical pledgets market growth.

Surgeons employ suturing techniques such as pledgeted horizontal mattress suture technique (utilizing two pledgets per stitch) to limit the risk of sutures cutting through tissues. Studies suggest that pledget reinforcement and traction compression are useful methods to achieve complete hemostasis after percutaneous endovascular procedures.

Numerous absorbable and non-absorbable pledgets are used for wound closure, depending on the surgeons’ considerations of its benefits to buffer the suture line.

In aortic valve replacement surgeries, it is argued that pledgeted sutures permit even distribution of mechanical forces, and therefore, a tighter connection between the prosthesis and the aortic annulus is achieved, lowering the incidence of complications such as paravalvular leak.

Surgeons also employ non-everting pledgeted mattress sutures to implant prosthesis during aortic valve replacement procedures.

Surgical sutures are composed of multiple synthetic and non-synthetic materials; of these, polytetrafluoroethylene (PTFE) pledgets are most commonly available. These are synthetic pledgets that are non-absorbable and commercially available in various pre-cut shapes such as round, oval, square, and rectangle.

Increase in Prevalence of Cardiovascular Disorders Augmenting U.K. Surgical Pledgets Market Value

As per estimates from the British Heart Foundation, approximately 7.6 million people living in the U.K. have cardiovascular disorders. These disorders or conditions include congenital heart defects as well as diseases that develop during the course of life such as coronary heart disease, atrial fibrillation, heart failure, stroke, and vascular dementia.

Cardiovascular disorders represent one of the leading causes of death in the U.K., with 27% of all deaths being linked to heart and circulatory diseases. More than 170,000 deaths are caused by these disorders annually in the U.K.

The annual death toll due to cardiovascular diseases is estimated to be around 49,000 for people aged under 75. Furthermore, coronary heart disease is responsible for nearly 68,000 deaths in the U.K. every year, an average of 190 deaths each day. This calls for increased awareness regarding such diseases and implementation of preventive strategies for high-risk population.

More than 25,000 adult cardiac surgeries were performed in the U.K. in 2022. Furthermore, nearly 11,500 congenital heart disease procedures were carried out in NHS hospitals in 2022.

Emergency and critical cardiac surgeries are essential to treat patients suffering from cardiovascular disorders. These surgeries often require several accessories, including surgical pledgets. This is driving the U.K. surgical pledgets market expansion.

Growth in Geriatric Population Fueling U.K. Surgical Pledgets Industry Growth

According to The World Population Prospects 2022 data, the percentage of global geriatric population aged above 65 is expected to rise from 10% in 2022 to 16% in 2050.

As per the Census 2021, the population of England and Wales has aged further. The number of people aged 65 years and above rose from 9.2 million in 2011 to more than 11 million in 2021. The percentage of people aged 65 years and above increased from 16.4% to 18.6%, during the same period.

The number of individuals aged 65 to 79 is anticipated to rise by 30% to more than 10 million in the next 40 years in England, while the number of people aged 80 and above, the fastest growing segment of the population, is set to more than double to over 6 million.

Thus, rise in burden of non-communicable diseases induced by the aging population is augmenting U.K. surgical pledgets market revenue.

High Demand for Synthetic Surgical Pledgets

Based on product type, the U.K. surgical pledgets market segmentation has been bifurcated into synthetic and non-synthetic.

Synthetic surgical pledgets currently hold significant market share in the U.K. Surgical pledgets composed of synthetic materials are reported to have negligible risk of contraindications and are therefore widely adopted. Additionally, easy accessibility & affordability of such products and availability of variety of shapes and sizes are factors that are driving the segment.

On the other hand, non-synthetic surgical pledgets are bioabsorbable and are composed of materials such as polyglycolide (PGA) fibers.

Rise in Adoption of Surgical Pledgets in Cardiac Surgeries

As per the U.K. surgical pledgets market analysis, the industry has been classified into cardiac surgery, thoracic surgery, and general surgery in terms of application.

U.K. surgical pledgets Market are commonly used in cardiac surgeries such as aortic valve replacement, coronary artery bypass graft, and mitral valve surgeries. Surge in prevalence of cardiac disorders in the U.K. is fueling the segment.

Analysis of Key Players

Companies operating in the U.K. surgical pledgets industry include Becton, Dickinson, and Company (BD), Medtronic plc, B. Braun Melsungen AG, DeRoyal Industries, Inc., Ethicon, Inc. (Johnson & Johnson Services, Inc.), Teleflex Incorporated, Boz Medical, Peters Surgical, Henry Schein, Inc., and Advanced MedTech Solutions Pvt. Ltd.

Each of these players have been have been profiled in the U.K. surgical pledgets market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

• In 2021, B. Braun entered into an agreement with IDENTI Medical to integrate the latter’s cloud software services for unique and complex management of surgical sutures inventory. Furthermore, the company announced its intention to incorporate IDENTI systems within its business model, enabling its large customer base to access these operating room management technologies.
• In June 2021, Ethicon became the first company to offer antibacterial sutures, Ethicon Plus Sutures, equipped with triclosan antibacterial protection. The Plus Sutures have been demonstrated to lower the risk of surgical site infections by 30%, thereby reducing SSI-related complications.
• In February 2021, DeRoyal Industries, Inc. signed a collaboration worth US$ 1.2 Mn with researchers from the Tyndall National Institute at UCC and RCSI, University of Medicine and Health Sciences, in order to innovate the next generation of compression wound care therapy

U.K. Surgical Pledgets Market Snapshot